Bribery, Corruption and the American Health Care Way

These days you just have to wonder about the greed and corruption that is going on all around. Senator Dick Blumenthal is one of many who’ve been pointing out the naked corruption in the Trump family–Qatari jets, memecoins, Trump’s son being on the board of so many defence and prediction market companies you can’t keep…

Read More

Why the CVS–Mass General Deal Would Likely Increase Spending More Than Access

A Massachusetts regulator is warning that CVS and Mass General Brigham’s proposed MinuteClinic partnership could drive up healthcare spending by at least $40 million annually, largely through steering patients into a higher-priced system. Experts said the deal might improve convenience for some patients but is unlikely to meaningfully expand access — and could ultimately strengthen…

Read More

Are drug prices value-based?

One of the central tensions in pharmaceutical policy is the gap between what a drug is worth and what it actually costs. In theory, a drug’s price should reflect its value — its ability to improve health outcomes relative to the next best alternative. In practice, list prices are set by manufacturers, net prices are shaped by opaque…

Read More